
GLP-1 diabetes drugs linked to increased risk of hair loss
Absolute risk low, but findings may help inform treatment decisions, say researchers Use of glucagon-like

Absolute risk low, but findings may help inform treatment decisions, say researchers Use of glucagon-like

Use of newer GLP-1 receptor agonists for obesity or diabetes was associated with a

Modulating intracellular signaling may extend drug effects A team of researchers at the National